This training is of an advanced level. A basic level of GMP knowledge is required to attend this training. The training program is not designed to address the basic theoretical principles of GMP. The practical implication of the GMP principles, real-life cases and the role of the QP are the focus of this training. A Qualified Person is expected to be aware of a number of pre-approval elements: an overview of the product life-cycle, Toxicology and the Registration Dossier. The training is highly interactive. The program is offered as a combination of self-study, theory, and practical case studies. The self-study prior to the module consists of reading preparatory materials.
Quality Management – The Role of the Qualified Person
Quality Management - Exploring the role of the Qualified Person
-
Based on 682 participants
GMP & GDP training for pharma & biotech
-
Language:
- 5 days in total
This training contains:
What you will learn
Identify elements of applicable GMP regulations and GMP expectations across the product life-cycle
Understand current regulatory developments and their business impact,
E.g., new regulations, the Falsified Medicines Directive (serialization) and significant issues that may impact the business
(Data integrity, drug shortages and supply chain integrity),
Apply the basic principles of quality management from a regulatory and business perspective
Training Dates
Quality Course Modules default to English, but will be in Dutch if all attendees are Dutch or Flemish-speaking.
| Dates | Language | Price | Register | |||
|---|---|---|---|---|---|---|
| 01/09/26 to 08/10/26 |
|
€ 3485.00 |
|
|||
|
Blok A starts 01/09/26 and ends 02/09/26.
what does this mean?
BlocksThis training is divided into blocks. It has two or more start/end dates. You must attend all blocks to complete the course. Blok B starts 06/10/26 and ends 08/10/26. |
||||||
Description
The Training
Target Audience
Professionals in pharmaceutical and biotechnological industries, Professionals in institutions and CRO’s, Hospital pharmacists and Postgraduate students.
The training is aimed at (young) professionals in non-clinical and clinical development of new medicinal products, production, packaging, Quality Control and Quality Assurance who are dealing with complex quality systems. The target audience needs to gain an in-depth understanding of these systems to improve quality management in their own organization.
The training is an international training program in English and requires, at minimum, a Bachelor’s Degree level (HBO level in the Netherlands).
This training is also suitable for openbaar apothekers and ziekenhuisapothekers, who will receive professional accreditation points.
(University) Students
Results
• Thorough understanding of the specific regulatory duties and responsibilities of senior management, functional leaders, the Qualified Person and Responsible Person.
• Insight into the integrated approach on Quality Management to safeguard product quality.
Tools to realize and improve, pro-actively and on an ongoing basis, effective quality management across the various stages of the product lifecycle.
Contents
- Quality Management as a good business practice across the product life-cycle
- Basic Principles of Quality Management
- The specific regulatory role and responsibility of the Qualified Person
- Quality Management System elements: deviation management, change control, RCA, validation & qualification, training and qualification of personnel, customer complaint management, audit systems and third-party operations
- Similarities and differences between local (small) organizations and global (large) organizations
- Current regulatory developments and (IGJ) inspection highlights
- The critical impact of culture and behavior on compliance
- Trending, Management Reviews and QP involvement
- The Registration Dossier: it’s development, life-cycle and the role of the QP
- Toxicology, including Health Based Exposure Limits
- From development to clinical to commercial
- QP experiences
- Industry, hospital environment, international setting
- Real-life challenges such as QP declarations and drug shortage prevention
- Real-life case studies
- Including participation in a team to work out a case study in the period between the first and second training sessions.
Programme
| Lecture | Day |
|---|---|
|
Introduction: The Roles and duties of the Qualified Person in Pharmaceutical Quality Management
|
1 |
|
Roadmap to realize Sustainable Quality and Regulatory Compliance Performance (IGJ)
|
1 |
|
Training, Qualifications and Roles & Responsibilities
|
1 |
|
Change Control
|
1 |
|
Deviation & CAPA Management
|
1 |
|
Complaint handling to recall (QP involvement)
|
1 |
| Lecture | Day |
|---|---|
|
Validation & qualification
|
2 |
|
QP Skills & Challenges
|
2 |
|
Trending and Management review and QP involvement
|
2 |
|
The QP Declaration
|
2 |
|
API & Excipients
|
2 |
|
Challenges of a QP in Industry
|
2 |
|
QP role in Hospital environment
|
2 |
|
Quality Control and the QP
|
2 |
|
Out-of-Specification (OOS) including batch decision: release or reject situation
|
2 |
| Lecture | Day |
|---|---|
|
The Critical Impact of Culture and Behavior: Introduction
|
3 |
|
Lessons from the Case Study Quality Culture & Behaviour
|
3 |
|
Case Study Presentation and Discussion: Risk Management (as per ICH Q9)
|
3 |
|
Case Study Presentation and Discussion: Deviation Management
|
3 |
|
Current regulatory development and inspection highlights (IGJ)
|
3 |
|
Questions & Answers and Discussion
|
3 |
| Lecture | Day |
|---|---|
|
Case Study Presentation and Discussion: Third Party Operations
|
4 |
|
Case Study Presentation and Discussion: Data Integrity
|
4 |
|
MAH responsibilities
|
4 |
|
The registration dossier - its development and life-cycle
|
4 |
|
The QP and the registration dossier
|
4 |
|
Critical points in scaling up (process from development to clinical to commercial)
|
4 |
|
From R&D lead to development active substance to pharmaceutical formulation
|
4 |
| Lecture | Day |
|---|---|
|
Toxicology & HBEL's
|
5 |
|
GLP basics
|
5 |
|
Safety and Pharmacovigilance
|
5 |
|
Investigational Medicinal Products and the QP
|
5 |
|
Workshop
|
5 |
|
End of the training, closing remarks
|
5 |
Quality Course modules
This module is part of a series called: "Quality Management in Pharma and Biotech". This series is designed to give participants an in-depth understanding of the QP’s role and responsibilities. See the other modules in this series below.
| Module | Date | Length | Price |
|---|---|---|---|
| Next edition: 27/10/26 | 3d | € 2719.00 | |
| Next edition: 24/11/26 | 3d | € 2719.00 | |
|
Quality Management - the Role of the Qualified Person
(Current Module)
|
Next edition: 01/09/26 | 5d | € 3485.00 |
| No dates planned | 2d | 0 |
Practical Information
- Accreditation:
-
- Openbaar Apothekers (KNMP), 30 Accreditation points
- Ziekenhuisapothekers (NVZA), 30 Accreditation points
- Difficulty / Level:
- Group discounts:
-
- 2 participants - 5%
- 3 participants - 10%
- 4 participants - 15%
- 4 participants - 20%
- 6+ participants - 25%
Group discounts are only applicable when multiple participants register for the same course at the same time.
- Language (upcoming edition):
-
-
English spoken language (primary)
-
Dutch spoken language (secondary)
- Some lectures/lessons may be in the secondary language. The primary language remains the dominant spoken/written language during the training.
-
- Learning form:
- Classroom
- Times:
- Starts at approx. 09:30 and ends at approx. 17:30
- Requires preparation:
-
Yes.
This module contains homework. The homework will be provided prior to the training.
- Includes exam:
- Yes.
- Exam price:
- €350.00 ex. VAT per participant.
- Notes to the course dinner:
-
For Block A, the dinner is scheduled on day 1. For Block B, it is on day 2.
Lecturers
Jolanda Muurman
Docent
Jolanda Muurman is a highly experienced GMP professional, former Qualified Person (QP) and traine...
Anna Myra Koopmans
Docent
Anna-Myra Koopmans is a highly experienced GMP and sterile manufacturing professional with over 3...
Christine Mitchell
Docent
Christine Mitchell is a highly experienced Quality Assurance professional and consultant with ove...
Tags
Reviews (120)
4 out of 5 stars
Based on 120 reviews
Review data
-
5 star reviews
- 31%
-
4 star reviews
- 60%
-
3 star reviews
- 8%
-
2 star reviews
- 1%
-
1 star reviews
- 0%
5 out of 5 stars
Strong points (and why):
Goede afwisseling tussen theorie en interactie
Anonymous - Anonymous
4 out of 5 stars
Strong points (and why):
Variations in topics and workshops
Review:
After lunch, do a workshop of have a light subject to discuss. For some workshops more explanations are needed beforehand.
Anonymous - Anonymous
4 out of 5 stars
Strong points (and why):
I like to have more case studies
Review:
More case studies
Ankita - RP/ senior QA officer
4 out of 5 stars
Strong points (and why):
Balance of workshops and lectures
Anonymous - Anonymous
4 out of 5 stars
Strong points (and why):
Het programma is gevarieerd
Review:
Misschien een workshop/ moment met deelnemers uit eenzelfde soort organisatie om knelpunten die specifiek op hen van toepassing zijn te beperken
Dieuwke van Gijssel - Ziekenhuisapotheker
4 out of 5 stars
Strong points (and why):
Enough time to ask questions. Interaction with whole group doing the cases and workshops in different groups
Review:
Keep a good mix between lecture and workshops.
Anonymous - QA manager
4 out of 5 stars
Strong points (and why):
Connection with other participants
Anonymous - Manager QA
4 out of 5 stars
Strong points (and why):
Interaction with other QP’s and professionality and experience sharing of the speakers
Review:
Commercial batchreview as a workshop; then linking to theory
Anonymous - QP, R&D
5 out of 5 stars
Strong points (and why):
The interactive way the information was presented and the possibility to ask questions in relation to individual situations
Haye van Beemen - Pharmacist
4 out of 5 stars
Strong points (and why):
Interaction Workshops Time for questions
Anonymous - Hospital pharmacist
4 out of 5 stars
Strong points (and why):
Interactive approach
Review:
For some presentations it was not clear what the role of the QP should be.
Ronald Smulders - Senior Director QA
4 out of 5 stars
Strong points (and why):
That it was interactive
Maniega - QP trainee
Related Courses
GMP for Mid-Level Management in the Pharmaceutical Industry
Based on 963 participants
Annex 1 (Practical Implementation of a Contamination Control Strategy)
Good Writing Practices
Based on 128 participants
GDP for the QP/RP Refresher
Good Distribution Practices (GDP) – also for the Responsible Person (classroom)
Based on 408 participants
External Audits & Self-inspections
Based on 405 participants